{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:45Z","timestamp":1792783365925,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kunming Medical University Graduate Innovation Fund","award":["2025S267"],"award-info":[{"award-number":["2025S267"]}],"id":[{"id":"https:\/\/ror.org\/038c3w259","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science Research Foundation of Yunnan Education Bureau","award":["2025J0186"],"award-info":[{"award-number":["2025J0186"]}]},{"name":"National Natural Science Foundation of China","award":["82160508"],"award-info":[{"award-number":["82160508"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yunnan Applied Basic Research Projects","award":["YNWRMY-2019-067"],"award-info":[{"award-number":["YNWRMY-2019-067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03360-0","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:26:14Z","timestamp":1788240374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNMT1 is associated with QDPR downregulation and chemotherapy response in lung adenocarcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Lyubo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"1","key":"3360_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3360_CR2","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.3322\/caac.70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043. https:\/\/doi.org\/10.3322\/caac.70043.","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"3360_CR3","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1200\/JCO-25-01062","volume":"43","author":"DH Owen","year":"2025","unstructured":"Owen DH, Halmos B, Puri S, Qin A, Ismaila N, Abu Rous F, Alluri K, Freeman-Daily J, Malhotra N, Marrone KA, et al. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1. J Clin Oncol. 2025;43(24):e45\u201358. https:\/\/doi.org\/10.1200\/JCO-25-01062.","journal-title":"J Clin Oncol"},{"issue":"16suppl","key":"3360_CR4","doi-asserted-by":"publisher","first-page":"e14635","DOI":"10.1200\/JCO.2024.42.16_suppl.e14635","volume":"42","author":"Z Lu","year":"2024","unstructured":"Lu Z, Xu S, Ye M, Shen T, Zhang X, Rao D, Chen J, Lin Z, Chang M, Xiong G, et al. Comparison of pembrolizumab plus chemotherapy versus concurrent or sequential radiochemotherapy in patients with driver mutation-lacking lung adenocarcinoma presenting with recurrent laryngeal nerve invasion leading to hoarseness. J Clin Oncol. 2024;42(16suppl):e14635\u201314635. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.e14635.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3360_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12272-021-01312-y","volume":"44","author":"H-Y Min","year":"2021","unstructured":"Min H-Y, Lee H-Y. Mechanisms of resistance to chemotherapy in non-small cell lung cancer. Arch Pharm Res. 2021;44(2):146\u201364. https:\/\/doi.org\/10.1007\/s12272-021-01312-y.","journal-title":"Arch Pharm Res"},{"key":"3360_CR6","doi-asserted-by":"publisher","unstructured":"Sengupta D, Zeng L, Li Y, Hausmann S, Ghosh D, Yuan G, Nguyen TN, Lyu R, Caporicci M, Morales Benitez A, et al. NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis. Mol Cell. 2021;81(21). https:\/\/doi.org\/10.1016\/j.molcel.2021.08.034.","DOI":"10.1016\/j.molcel.2021.08.034"},{"issue":"19","key":"3360_CR7","doi-asserted-by":"publisher","first-page":"8903","DOI":"10.7150\/thno.45785","volume":"10","author":"J-E Wu","year":"2020","unstructured":"Wu J-E, Wu Y-Y, Tung C-H, Tsai Y-T, Chen H-Y, Chen Y-L, Hong T-M. DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression. Theranostics. 2020;10(19):8903\u201323. https:\/\/doi.org\/10.7150\/thno.45785.","journal-title":"Theranostics"},{"issue":"1","key":"3360_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","volume":"25","author":"M Li","year":"2024","unstructured":"Li M, Deng X, Zhou D, Liu X, Dai J, Liu Q. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma. Curr Genomics. 2024;25(1):26\u201340. https:\/\/doi.org\/10.2174\/0113892029277397231228062412.","journal-title":"Curr Genomics"},{"issue":"5","key":"3360_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41388-024-03220-z","volume":"44","author":"H Li","year":"2024","unstructured":"Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, Mu Y, Shen W, Tong J, Chen H, et al. RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene. 2024;44(5):307\u201321. https:\/\/doi.org\/10.1038\/s41388-024-03220-z.","journal-title":"Oncogene"},{"issue":"1","key":"3360_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/0113892029298721240627095839","volume":"26","author":"Q Ren","year":"2024","unstructured":"Ren Q, Ma H, Wang L, Qin J, Tian M, Zhang W. Gene-knockdown Methods for Silencing Nuclear-localized Insulin Receptors in Lung Adenocarcinoma Cells: A Bioinformatics Approach. Curr Genomics. 2024;26(1):24\u201335. https:\/\/doi.org\/10.2174\/0113892029298721240627095839.","journal-title":"Curr Genomics"},{"issue":"6","key":"3360_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/0113892029382696251125102036","volume":"26","author":"G Yang","year":"2026","unstructured":"Yang G, Yu J, Deng X, Dai J, Liu Q. Unveiling the Role of Sialylation-Related LncRNAs in Lung Adenocarcinoma: A New Prognostic Model. Curr Genomics. 2026;26(6):653\u201372. https:\/\/doi.org\/10.2174\/0113892029382696251125102036.","journal-title":"Curr Genomics"},{"issue":"1","key":"3360_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13072-023-00490-x","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Dai L, Liu Y, Li C, Fan D, Zhou Y, Li P, Kong Q, Su J. Partial erosion on under-methylated regions and chromatin reprogramming contribute to oncogene activation in IDH mutant gliomas. Epigenetics Chromatin. 2023;16(1):13. https:\/\/doi.org\/10.1186\/s13072-023-00490-x.","journal-title":"Epigenetics Chromatin"},{"issue":"7","key":"3360_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1101\/gr.132662.111","volume":"22","author":"SA Selamat","year":"2012","unstructured":"Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 2012;22(7):1197\u2013211. https:\/\/doi.org\/10.1101\/gr.132662.111.","journal-title":"Genome Res"},{"issue":"4","key":"3360_CR14","doi-asserted-by":"publisher","first-page":"189356","DOI":"10.1016\/j.bbcan.2025.189356","volume":"1880","author":"Y Xu","year":"2025","unstructured":"Xu Y, Meng Y, Xu Y, Han J, Zhu Q. Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance. Biochim Biophys Acta Rev Cancer. 2025;1880(4):189356. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189356.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"19","key":"3360_CR15","doi-asserted-by":"publisher","first-page":"e38663","DOI":"10.1016\/j.heliyon.2024.e38663","volume":"10","author":"K Mohd Kamal","year":"2024","unstructured":"Mohd Kamal K, Ghazali AR, Ab Mutalib NS, Abu N, Chua EW, Masre SF. The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC). Heliyon. 2024;10(19):e38663. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38663.","journal-title":"Heliyon"},{"issue":"2","key":"3360_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/0109298665254683231122065717","volume":"31","author":"Z Qin","year":"2024","unstructured":"Qin Z, Xu Y. Dexmedetomidine Alleviates Brain Ischemia\/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1\/MicroRNA-140-5p\/ Nuclear Factor Erythroid-derived 2-like 2 Axis. Protein Pept Lett. 2024;31(2):116\u201327. https:\/\/doi.org\/10.2174\/0109298665254683231122065717.","journal-title":"Protein Pept Lett"},{"key":"3360_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, et al. Mendelian randomization. Nat Rev Methods Primers. 2022. https:\/\/doi.org\/10.1038\/s43586-021-00092-5. 2.","journal-title":"Nat Rev Methods Primers"},{"key":"3360_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/447367","author":"U V\u00f5sa","year":"2018","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Kasela S et al: Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis. bioRxiv 2018:447367. https:\/\/doi.org\/10.1101\/447367","journal-title":"bioRxiv"},{"issue":"12","key":"3360_CR19","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV et al: Large-scale integration of the plasma proteome with genetics and disease. Nature Genetics 2021, 53(12):1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w","journal-title":"Nature Genetics"},{"issue":"1","key":"3360_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13059-016-0926-z","volume":"17","author":"TR Gaunt","year":"2016","unstructured":"Gaunt TR, Shihab HA, Hemani G, Min JL, Woodward G, Lyttleton O, Zheng J, Duggirala A, McArdle WL, Ho K et al: Systematic identification of genetic influences on methylation across the human life course. Genome Biology 2016, 17(1):61. https:\/\/doi.org\/10.1186\/s13059-016-0926-z","journal-title":"Genome Biology"},{"issue":"1","key":"3360_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12935-024-03382-6","volume":"24","author":"W Fan","year":"2024","unstructured":"Fan W, Xing Y, Yan S, Liu W, Ning J, Tian F, Wang X, Zhan Y, Luo L, Cao M, et al. DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-\u03b2\/Smad signaling pathway in lung adenocarcinoma. Cancer Cell Int. 2024;24(1):208. https:\/\/doi.org\/10.1186\/s12935-024-03382-6.","journal-title":"Cancer Cell Int"},{"key":"3360_CR22","doi-asserted-by":"publisher","unstructured":"Birney E. Mendelian Randomization. Cold Spring Harbor Perspect Med. 2022;12(4). https:\/\/doi.org\/10.1101\/cshperspect.a041302.","DOI":"10.1101\/cshperspect.a041302"},{"issue":"3","key":"3360_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3360_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"3360_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/02770903.2024.2403740","volume":"62","author":"S Xu","year":"2024","unstructured":"Xu S, Liang J, Shen T, Zhang D, Lu Z. Causal links between immune cells and asthma: Insights from a Mendelian Randomization analysis. J Asthma. 2024;62(2):346\u201353. https:\/\/doi.org\/10.1080\/02770903.2024.2403740.","journal-title":"J Asthma"},{"issue":"1","key":"3360_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s43586-022-00099-6","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, et al. Mendelian randomization. Nat Reviews Methods Primers. 2022;2(1):7. https:\/\/doi.org\/10.1038\/s43586-022-00099-6.","journal-title":"Nat Reviews Methods Primers"},{"issue":"2","key":"3360_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"key":"3360_CR28","doi-asserted-by":"publisher","first-page":"164202","DOI":"10.1016\/j.cej.2025.164202","volume":"516","author":"W Luo","year":"2025","unstructured":"Luo W, Pan X, Ren C, Wang T, Li G, Jin L, Zhang D. Anti-swelling and ROS-scavenging nanofiber hydrogel to prevent postoperative abdominal adhesion. Chem Eng J. 2025;516:164202. https:\/\/doi.org\/10.1016\/j.cej.2025.164202.","journal-title":"Chem Eng J"},{"key":"3360_CR29","doi-asserted-by":"publisher","first-page":"167519","DOI":"10.1016\/j.cej.2025.167519","volume":"522","author":"X Pan","year":"2025","unstructured":"Pan X, Zhu P, Ding Y, Di C, Yang Z, Zhou H, Li C, Jin L. Engineered honeysuckle extracellular vesicles loaded in ROS response hydrogel for inhibition of postoperative abdominal adhesion. Chem Eng J. 2025;522:167519. https:\/\/doi.org\/10.1016\/j.cej.2025.167519.","journal-title":"Chem Eng J"},{"issue":"4","key":"3360_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/procel\/pwad038","volume":"15","author":"Y Mao","year":"2023","unstructured":"Mao Y, Wang W, Yang J, Zhou X, Lu Y, Gao J, Wang X, Wen L, Fu W, Tang F. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids. Protein Cell. 2023;15(4):285\u2013304. https:\/\/doi.org\/10.1093\/procel\/pwad038.","journal-title":"Protein Cell"},{"issue":"1","key":"3360_CR31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/s12967-024-05512-0","volume":"22","author":"R Yang","year":"2024","unstructured":"Yang R, Qi Y, Kwan W, Du Y, Yan R, Zang L, Yao X, Li C, Zhu Z, Zhang X, et al. Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine. J Transl Med. 2024;22(1):754. https:\/\/doi.org\/10.1186\/s12967-024-05512-0.","journal-title":"J Transl Med"},{"key":"3360_CR32","doi-asserted-by":"publisher","unstructured":"Sanderson E. Multivariable Mendelian Randomization and Mediation. Cold Spring Harb Perspect Med. 2021;11(2). https:\/\/doi.org\/10.1101\/cshperspect.a038984.","DOI":"10.1101\/cshperspect.a038984"},{"issue":"2","key":"3360_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s10038-018-0529-5","volume":"64","author":"S Kure","year":"2019","unstructured":"Kure S, Shintaku H. Tetrahydrobipterin-responsive phenylalanine hydroxylase deficiency. J Hum Genet. 2019;64(2):67\u201371. https:\/\/doi.org\/10.1038\/s10038-018-0529-5.","journal-title":"J Hum Genet"},{"issue":"5","key":"3360_CR34","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cmet.2024.03.015","volume":"36","author":"J Liu","year":"2024","unstructured":"Liu J, He X, Deng S, Zhao S, Zhang S, Chen Z, Xue C, Zeng L, Zhao H, Zhou Y, et al. QDPR deficiency drives immune suppression in pancreatic cancer. Cell Metabol. 2024;36(5):984\u2013e999988. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.015.","journal-title":"Cell Metabol"},{"key":"3360_CR35","doi-asserted-by":"publisher","first-page":"1321326","DOI":"10.3389\/fonc.2023.1321326","volume":"13","author":"GC Clark","year":"2024","unstructured":"Clark GC, Lai A, Agarwal A, Liu Z, Wang X-Y. Biopterin metabolism and nitric oxide recoupling in cancer. Front Oncol. 2024;13:1321326. https:\/\/doi.org\/10.3389\/fonc.2023.1321326.","journal-title":"Front Oncol"},{"issue":"12","key":"3360_CR36","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1111\/cas.70202","volume":"116","author":"Y Nakano","year":"2025","unstructured":"Nakano Y, Tanaka M, Sakamoto T, Hashimoto M, Tobo T, Saito H, Abe T, Ikehara T, Ofuchi T, Kawata K, et al. Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma. Cancer Sci. 2025;116(12):3352\u201366. https:\/\/doi.org\/10.1111\/cas.70202.","journal-title":"Cancer Sci"},{"key":"3360_CR37","doi-asserted-by":"publisher","first-page":"112802","DOI":"10.1016\/j.exger.2025.112802","volume":"207","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li J, Qiao H, Zhang Y, Xu Y, Chen R, Liu K, Zhang S, Zhuang G. Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study. Exp Gerontol. 2025;207:112802. https:\/\/doi.org\/10.1016\/j.exger.2025.112802.","journal-title":"Exp Gerontol"},{"issue":"2","key":"3360_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale I, Shema E, Loi S, Galluzzi L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021;27(2):212\u201324. https:\/\/doi.org\/10.1038\/s41591-021-01233-9.","journal-title":"Nat Med"},{"issue":"1","key":"3360_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ije\/dyr233","volume":"41","author":"CL Relton","year":"2012","unstructured":"Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41(1):161\u201376. https:\/\/doi.org\/10.1093\/ije\/dyr233.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"3360_CR40","doi-asserted-by":"publisher","first-page":"101008","DOI":"10.1016\/j.waojou.2024.101008","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Hu J, Qin D, Han D, Hu J. A multi-omics Mendelian randomization identifies putatively causal genes and DNA methylation sites for asthma. World Allergy Organ J. 2024;17(12):101008. https:\/\/doi.org\/10.1016\/j.waojou.2024.101008.","journal-title":"World Allergy Organ J"},{"issue":"2","key":"3360_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1183\/09031936.00042409","volume":"34","author":"S Ocak","year":"2009","unstructured":"Ocak S, Sos ML, Thomas RK, Massion PP. High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications. Eur Respir J. 2009;34(2):489\u2013506. https:\/\/doi.org\/10.1183\/09031936.00042409.","journal-title":"Eur Respir J"},{"issue":"28","key":"3360_CR42","doi-asserted-by":"publisher","first-page":"44129","DOI":"10.18632\/oncotarget.9866","volume":"7","author":"J Bai","year":"2016","unstructured":"Bai J, Zhang X, Hu K, Liu B, Wang H, Li A, Lin F, Zhang L, Sun X, Du Z, et al. Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK. Oncotarget. 2016;7(28):44129\u201341. https:\/\/doi.org\/10.18632\/oncotarget.9866.","journal-title":"Oncotarget"},{"issue":"1","key":"3360_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-18-0689","volume":"9","author":"S Kitajima","year":"2019","unstructured":"Kitajima S, Ivanova E, Guo S, Yoshida R, Campisi M, Sundararaman SK, Tange S, Mitsuishi Y, Thai TC, Masuda S, et al. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer. Cancer Discov. 2019;9(1):34\u201345. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0689.","journal-title":"Cancer Discov"},{"key":"3360_CR44","doi-asserted-by":"publisher","unstructured":"Meng X, Chen Y, Gao Y, Geng D, Tang Y. ADHD classification with cross-dataset feature selection for biomarker consistency detection. J Neural Eng. 2024;21(3). https:\/\/doi.org\/10.1088\/1741-2552\/ad48bd.","DOI":"10.1088\/1741-2552\/ad48bd"},{"issue":"6880","key":"3360_CR45","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/416552a","volume":"416","author":"I Rhee","year":"2002","unstructured":"Rhee I, Bachman KE, Park BH, Jair K-W, Yen R-WC, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416(6880):552\u20136.","journal-title":"Nature"},{"issue":"1","key":"3360_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ng1068","volume":"33","author":"M-F Robert","year":"2002","unstructured":"Robert M-F, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2002;33(1):61\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"3360_CR47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s13402-020-00526-4","volume":"43","author":"KK Wong","year":"2020","unstructured":"Wong KK. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cell Oncol (Dordr). 2020;43(5):779\u201392. https:\/\/doi.org\/10.1007\/s13402-020-00526-4.","journal-title":"Cell Oncol (Dordr)"},{"key":"3360_CR48","doi-asserted-by":"publisher","first-page":"115753","DOI":"10.1016\/j.biopha.2023.115753","volume":"168","author":"L Yan","year":"2023","unstructured":"Yan L, Geng Q, Cao Z, Liu B, Li L, Lu P, Lin L, Wei L, Tan Y, He X, et al. Insights into DNMT1 and programmed cell death in diseases. Biomed Pharmacother. 2023;168:115753. https:\/\/doi.org\/10.1016\/j.biopha.2023.115753.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3360_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/toxsci\/kfac004","volume":"187","author":"H Zhang","year":"2022","unstructured":"Zhang H, Pan Z, Ling X, Tan Q, Yuan Q, Qin J, Zhong B, Li H, Chen J, Zhang H, et al. LINC00173 Interacts With DNMT1 to Regulate LINC00173 Expression via Promoter Methylation in Hydroquinone-Induced Malignantly Transformed TK6 Cells and Benzene-Exposed Workers. Toxicol Sci. 2022;187(2):311\u201324. https:\/\/doi.org\/10.1093\/toxsci\/kfac004.","journal-title":"Toxicol Sci"},{"issue":"1","key":"3360_CR50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13148-025-01959-0","volume":"17","author":"B Nuttall","year":"2025","unstructured":"Nuttall B, Karl DL, Burke K, Callahan M, Mendler K, Cingolani P, Criscione S, Naumenko S, Bibikova E, Munugalavadla V, et al. Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples. Clin Epigenetics. 2025;17(1):156. https:\/\/doi.org\/10.1186\/s13148-025-01959-0.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"3360_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s13402-025-01078-1","volume":"48","author":"T Guo","year":"2025","unstructured":"Guo T, Liu L, Zeng L, Yang Y, Song T, Zhao H, Qiu Z. GMPS inhibits the proliferation and migration of non-small cell lung cancer via the regulation of the DNMT 1\/SERPINB2 axis. Cell Oncol (Dordr). 2025;48(4):1145\u201358. https:\/\/doi.org\/10.1007\/s13402-025-01078-1.","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"3360_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/jb\/mvaa034","volume":"168","author":"X-Y Wu","year":"2020","unstructured":"Wu X-Y, Chen H-C, Li W-W, Yan J-D, Lv R-Y. DNMT1 promotes cell proliferation via methylating hMLH1 and hMSH2 promoters in EGFR-mutated non-small cell lung cancer. J Biochem. 2020;168(2):151\u20137. https:\/\/doi.org\/10.1093\/jb\/mvaa034.","journal-title":"J Biochem"},{"issue":"1","key":"3360_CR53","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1038\/s41467-023-42417-w","volume":"14","author":"A Goyal","year":"2023","unstructured":"Goyal A, Bauer J, Hey J, Papageorgiou DN, Stepanova E, Daskalakis M, Scheid J, Dubbelaar M, Klimovich B, Schwarz D, et al. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts. Nat Commun. 2023;14(1):6731. https:\/\/doi.org\/10.1038\/s41467-023-42417-w.","journal-title":"Nat Commun"},{"issue":"30","key":"3360_CR54","doi-asserted-by":"publisher","first-page":"18480","DOI":"10.1074\/jbc.M114.633693","volume":"290","author":"F Yan","year":"2015","unstructured":"Yan F, Shen N, Pang J, Molina JR, Yang P, Liu S. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2\u2019-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells. J Biol Chem. 2015;290(30):18480\u201394. https:\/\/doi.org\/10.1074\/jbc.M114.633693.","journal-title":"J Biol Chem"},{"issue":"9","key":"3360_CR55","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-13-2088","volume":"20","author":"PM Forde","year":"2014","unstructured":"Forde PM, Brahmer JR, Kelly RJ. New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer. Clin Cancer Res. 2014;20(9):2244\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2088.","journal-title":"Clin Cancer Res"},{"key":"3360_CR56","doi-asserted-by":"publisher","first-page":"100321","DOI":"10.1016\/j.jbo.2020.100321","volume":"25","author":"P Chaiyawat","year":"2020","unstructured":"Chaiyawat P, Sirikaew N, Budprom P, Klangjorhor J, Phanphaisarn A, Teeyakasem P, Settakorn J, Pruksakorn D. Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma. J Bone Oncol. 2020;25:100321. https:\/\/doi.org\/10.1016\/j.jbo.2020.100321.","journal-title":"J Bone Oncol"},{"key":"3360_CR57","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, Lu Z, Xu S, Qin Y, Zhao L, Zhang C. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936. https:\/\/doi.org\/10.3389\/fimmu.2026.1790936.","journal-title":"Front Immunol"},{"issue":"4","key":"3360_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamaoncol.2025.6508","volume":"12","author":"S Xu","year":"2026","unstructured":"Xu S, Guo Q, Lu Z. Physical Activity, Lifestyle, and Cancer Risk. JAMA Oncol. 2026;12(4):425\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2025.6508.","journal-title":"JAMA Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03360-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:08Z","timestamp":1792096928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03360-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3360"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03360-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all patients prior to tissue collection. The study protocol was reviewed and approved by the Ethics Committee of Yunnan Cancer Hospital (Approval No. KYLX2026-095).","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"264"}}